6 天
GlobalData on MSNUSPTO grants patent to Vistagen’s neuropathic pain treatmentThe US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...
Algiax Pharmaceuticals, a company committed to developing innovative treatments for chronic neuropathic pain, has released ...
Nerve pain refers to painful sensations around the nerves. Various treatment options are available, including anticonvulsants, certain antidepressants, mild opioids, and some topical treatments.
Objective: To assess the efficacy, safety and impact on quality of life of tramadol in the treatment of neuropathic pain in patients with cancer. Methods: Patients with similar characteristics ...
14 天
News Medical on MSNCancer drugs cause chronic peripheral nerve pain in 40% of patientsWorldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
Navigation Menu Toggle navigation Sign in ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved in pain signaling. A major breakthrough in our understanding of pain ...
Cannabidiol (CBD) holds promise as a treatment for many health concerns, including inflammation. For all the known benefits CBD offers, it’s unclear how well it can relieve nerve pain.
Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果